IJMPCERO  Vol.7 No.3 , August 2018
Investigation of Hot-Spots in TomoDirect 3DCRT Breast Treatment
Abstract: Background: Conventional tomotherapy platforms only allow for the delivery of helical IMRT. However the use of IMRT and helical delivery in breast cancer treatment is non-standard. Newer tomotherapy units are equipped with a static-beam mode with 3DCRT capabilities. During the clinical use, we frequently observe hot-spots in the plan that renders the plan clinically unacceptable. The purpose of this study is to investigate the underlying cause of the hot-spots in tomotherapy static-beam breast treatment and possible solutions. Materials/Methods: Theories about the formation of the hot-spot were developed. Eight lumpectomy patients contoured according to RTOG-1005 specifications were also used to illustrate the magnitude of hot-spots under various planning strategies. Two tangential beams were used for the whole breast irradiation plan with prescription dose of 40 Gy in 15 fractions. Results: The hot-spot was identified as the behavior of the optimization engine when part of the target region was blocked. With the current design of tomotherapy’s 3DCRT planning where user adjustment was greatly limited, none of the planning strategies were able to reduce the hot-spots to acceptable levels in the eight patients studied. The best strategy still produced an average of 48.5 Gy (121% of prescription dose) hot-spot dose and 30.4 cc hot-spot volume (volume receiving > 110% prescription dose). It is also shown that the hot-spot was not a result of energy or other physical limitation of the radiation device. By manually adjusting the plan sinogram, the maximum hot-spot dose drops from 121% to 111% and the hot-spot volume drops from 30 cc to 6 cc on average. Conclusions: While TomoDirect 3DCRT showed great promise in breast treatment, treatment planning software improvements may be needed in order to improve the clinical acceptability by reducing hot-spots in normal tissue.
Cite this paper: Chen, Q. , Mallory, M. , Crandley, E. and Khandelwal, S. (2018) Investigation of Hot-Spots in TomoDirect 3DCRT Breast Treatment. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 7, 376-390. doi: 10.4236/ijmpcero.2018.73031.

[1]   Arriagada, R., Le, M.G., Rochard, F. and Contesso, G. (1996) Conservative Treatment versus Mastectomy in Early Breast Cancer: Patterns of Failure with 15 Years of Follow-Up Data. Institut Gustave-Roussy Breast Cancer Group. Journal of Clinical Oncology, 14, 1558-1564.

[2]   Blichert-Toft, M., Nielsen, M., During, M., et al. (2008) Long-Term Results of Breast Conserving surgery vs. Mastectomy for Early Stage Invasive Breast Cancer: 20-year Follow-Up of the Danish Randomized DBCG-82TM Protocol. Acta Oncologica, 47, 672-681.

[3]   Blichert-Toft, M., Rose, C., Andersen, J.A., et al. (1992) Danish Randomized Trial Comparing Breast Conservation Therapy with Mastectomy: Six Years of Life-Table Analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr, 19-25.

[4]   Fisher, B., Anderson, S., Bryant, J., et al. (2002) Twenty-Year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer. The New England Journal of Medicine, 347, 1233-1241.

[5]   Poggi, M.M., Danforth, D.N., Sciuto, L.C., et al. (2003) Eighteen-Year Results in the Treatment of Early Breast Carcinoma with Mastectomy versus Breast Conservation Therapy: The National Cancer Institute Randomized Trial. Cancer, 98, 697-702.

[6]   van Dongen, J.A., Voogd, A.C., Fentiman, I.S., et al. (2000) Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy with Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. Journal of the National Cancer Institute, 92, 1143-1150.

[7]   Veronesi, U., Cascinelli, N., Mariani, L., et al. (2002) Twenty-Year Follow-Up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer. The New England Journal of Medicine, 347, 1227-1232.

[8]   Anderson, S.J., Wapnir, I., Dignam, J.J., et al. (2009) Prognosis after Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer. Journal of Clinical Oncology, 27, 2466-2473.

[9]   Wapnir, I.L., Anderson, S.J., Mamounas, E.P., et al. (2006) Prognosis after Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Five National Surgical Adjuvant Breast and Bowel Project Node-Positive Adjuvant Breast Cancer Trials. Journal of Clinical Oncology, 24, 2028-2037.

[10]   Fields, E.C., Rabinovitch, R., Ryan, N.E., Miften, M. and Westerly, D.C. (2013) A Detailed Evaluation of TomoDirect 3DCRT Planning for Whole-Breast Radiation Therapy. Medical Dosimetry, 38, 401-406.

[11]   Barnett, G.C., Wilkinson, J., Moody, A.M., et al. (2009) A Randomised Controlled Trial of Forward-Planned Radiotherapy (IMRT) for Early Breast Cancer: Baseline Characteristics and Dosimetry Results. Radiotherapy and Oncology, 92, 34-41.

[12]   Fogliata, A., Nicolini, G., Alber, M., et al. (2005) IMRT for Breast. A Planning Study. Radiotherapy and Oncology, 76, 300-310.

[13]   Schubert, L.K., Gondi, V., Sengbusch, E., et al. (2011) Dosimetric Comparison of Left-Sided Whole Breast Irradiation with 3DCRT, Forward-Planned IMRT, Inverse-Planned IMRT, Helical Tomotherapy, and Topotherapy. Radiotherapy and Oncology, 100, 241-246.

[14]   Freedman, G.M., Anderson, P.R., Li, J., et al. (2006) Intensity Modulated Radiation Therapy (IMRT) Decreases Acute Skin Toxicity for Women Receiving Radiation for Breast Cancer. American Journal of Clinical Oncology, 29, 66-70.

[15]   Pignol, J.P., Olivotto, I., Rakovitch, E., et al. (2008) A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis. Journal of Clinical Oncology, 26, 2085-2092.

[16]   Dayes, I., Rumble, R.B., Bowen, J., et al. (2012) Intensity-Modulated Radiotherapy in the Treatment of Breast Cancer. Clinical Oncology, 24, 488-498.

[17]   Smith, B.D., Pan, I.W., Shih, Y.C., et al. (2011) Adoption of Intensity-Modulated Radiation Therapy for Breast Cancer in the United States. Journal of the National Cancer Institute, 103, 798-809.

[18]   Mackie, T.R., Holmes, T., Swerdloff, S., et al. (1993) Tomotherapy: A New Concept for the Delivery of Dynamic Conformal Radiotherapy. Medical Physics, 20, 1709-1719.

[19]   Oliver, M., Ansbacher, W. and Beckham, W.A. (2009) Comparing Planning Time, Delivery Time and Plan Quality for IMRT, Rapid Arc and Tomotherapy. Journal of Applied Clinical Medical Physics, 10, 117-131.

[20]   Jones, R., Yang, W., Read, P. and Sheng, K. (2011) Radiation Therapy of Post-Mastectomy Patients with Positive Nodes Using Fixed Beam Tomotherapy. Radiotherapy and Oncology, 100, 247-252.

[21]   Fraass, B.A., Steers, J.M., Matuszak, M.M. and McShan, D.L. (2012) Inverse-Optimized 3D Conformal Planning: Minimizing Complexity while Achieving Equivalence with Beamlet IMRT in Multiple Clinical Sites. Medical Physics, 39, 3361-3374.

[22]   Borca, V.C., Franco, P., Catuzzo, P., et al. (2012) Does TomoDirect 3DCRT Represent a Suitable Option for Post-Operative Whole Breast Irradiation? A Hypothesis-Generating Pilot Study. Radiation Oncology, 7, 211.

[23]   RTOG1005: A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation plus Concurrent Boost versus Standard Whole Breast Irradiation plus Sequential Boost for Early-Stage Breast Cancer.

[24]   Chen, Q., Chen, M. and Lu, W. (2011) Ultrafast Convolution/Superposition Using Tabulated and Exponential Kernels on GPU. Medical Physics, 38, 1150-1161.

[25]   Chen, Q., Lu, W., Chen, Y., et al. (2012) Validation of GPU Based TomoTherapy Dose Calculation Engine. Medical Physics, 39, 1877-1886.

[26]   Lu, W. (2010) A Non-Voxel-Based Broad-Beam (NVBB) Framework for IMRT Treatment Planning. Physics in Medicine & Biology, 55, 7175-7210.

[27]   Lu, W. and Chen, M. (2010) Fluence-Convolution Broad-Beam (FCBB) Dose Calculation. Physics in Medicine & Biology, 55, 7211-7229.

[28]   Stovall, M., Smith, S.A., Langholz, B.M., et al. (2008) Dose to the Contralateral Breast from Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study. International Journal of Radiation Oncology, Biology, Physics, 72, 1021-1030.

[29]   Hashimoyo, H., Omura, M., Matsui, K., et al. (2015) Tangent Field Technique of TomoDirect Improves Dose Distribution for Whole-Breast Irradiation. Journal of Applied Clinical Medical Physics, 16, 5369.

[30]   Reynders, T., Tournel, K., De Coninck, P., et al. (2009) Dosimetric Assessment of Static and Helical TomoTherapy in the Clinical Implementation of Breast Cancer Treatments. Radiotherapy and Oncology, 93, 71-79.

[31]   Yadav, P., Yan, Y., Ignatowski, T. and Olson, A. (2017) Dosimetric Aspects of Breast Radiotherapy with Three-Dimensional and Intensity-Modulated Radiotherapy Helical Tomotherapy Planning Modules. Medical Dosimetry, 42, 42-46.